LIONEX Diagnostics & Therapeutics

LIONEX Diagnostics & Therapeutics is a private German biotech and in vitro diagnostics company based in Braunschweig with a strong focus on tuberculosis and other mycobacterial diseases. The company develops, manufactures, and commercializes diagnostic products including the LIOFeron TB/LTBI IGRA test, LIODetect rapid tests, tuberculosis ELISA assays, and bovine TB research tests. LIONEX also supplies mycobacterial antigens, monoclonal antibodies, recombinant proteins, and endotoxin-removal products such as EndoTrap, and offers OEM and contract manufacturing services for lateral flow and other IVD products. In addition to commercial diagnostics and research tools, the company has described research-stage vaccine and therapeutic efforts in infectious disease and bladder cancer. Its operations are centered in Germany under ISO 13485-certified manufacturing conditions.